Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 2013

View Archived Issues

Research uncovers benefit of combined PI3K/mTOR and JAK2 inhibition

PET imaging agent predicts response to liposomal chemotherapeutics

New GPR119 receptor agonists presented by Taisho Pharmaceutical

Regeneron Pharmaceuticals patents novel antibodies to hANGPTL3

Novel catechol derivatives presented by Edison Pharmaceuticals

Eli Lilly presents novel aldosterone synthase inhibitors

GlobeImmune patents new hepatitis D vaccines

New endothelial lipase inhibitors synthesized at Shionogi & Co.

p25/Cdk5 targeting shows promise in animal models of neurodegenerative disease

Novartis Pharma launches Tobi for respiratory infection in cystic fibrosis in Japan

SanBio enrolls second patient cohort in SB-623 stem cell trial

GlaxoSmithKline submits albiglutide BLA

Quillivant XR oral suspension launched in the U.S.

Epadel completes phase II study in NASH

BioTime submits protocol to initiate human trials of Renevia in Europe

Patrys progresses phase I/IIa PAT-SM6 trial to second patient group

Neuralstem cleared to conduct phase I trial of stem cell product in spinal cord injury

Uluru launches Altrazeal blister pack in the U.S.

Reviva completes enrollment in phase II trial of RP-5063

VG Life Sciences expands phase I ovarian cancer trial into all solid tumors

FDA approves Uceris for induction of remission in ulcerative colitis

Sanofi launches Amaryl OD 0.5 mg in Japan

Bayer Healthcare patents novel Mnk1 inhibitors for cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...